What is phosphatidyl serine

At present, the population structure of China has changed greatly. According to the data published by the National Planning Commission, by 2016, the aging population over 60 years of age in China has reached 230 million, accounting for 16.7% of the total population, and China has quickly stepped into the aging society. At present, there are 5 million patients with Alzheimer's disease (46 million 800 thousand) in China (the world), and the number of them is rising rapidly. It has brought serious health problems, economic burdens and social problems to the patients and their families and society. Therefore, it is very urgent to develop various effective medical and health products and prevent Alzheimer's disease.

Phosphatidyl serine (PS), the only active ingredient in the United States' FDA officially approved to prevent and mitigate the symptoms of Alzheimer's disease, has a very important position in the global brain health field. The global market capacity is 200-300 tons / year (the price is maintained at 25-39 US dollars / ton), and the trend of maintaining steady and steady growth is wide.